Summit Global Investments’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Summit Global Investments's LMAT Position: Q2 2026 in Review
Summit Global Investments increased its LeMaitre Vascular (LMAT) stake by 7% in Q2 2026, buying an estimated $25.5K and bringing the position to 3,803 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #406.
Summit Global Investments first reported a position in LMAT in Q2 2017 and has held it in 15 quarters since. The position peaked at $1.1M in Q4 2023. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Summit Global Investments held 3,803 shares of LeMaitre Vascular worth $365K as of Q2 2026.
- Summit Global Investments bought 249 LeMaitre Vascular shares in Q2 2026, an estimated $25.5K.
- LeMaitre Vascular made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #406 holding.
- Summit Global Investments first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 15 quarters since.
- Summit Global Investments's LeMaitre Vascular position peaked at $1.1M in Q4 2023.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.